Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

The summary for the Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional): This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (US).
Federal Grant Title: Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education, Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-24-207
Type of Funding: Grant
CFDA Numbers: 93.279, 93.307, 93.393
CFDA Descriptions: Information not provided
Current Application Deadline: January 7th, 2028
Original Application Deadline: January 7th, 2028
Posted Date: May 13th, 2024
Creation Date: May 13th, 2024
Archive Date: February 12th, 2028
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: May 14th, 2024
Applicants Eligible for this Grant
Public and State controlled institutions of higher education - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-24-207.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Solutions to enable diagnosis and treatment of adverse health consequences of non-disorder...
Solutions to enable diagnosis and treatment of adverse health consequences of non-disorder...
Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiolog...
HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical T...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Canc...
Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not A...
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Option...
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Op...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com